Muhindo Mavoko, Hypolite <br/><br/>
Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.  [electronic resource] 

 -  Trials  Sep 2013 
 - 307 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1745-6215 
<br/><br/><label>Standard No.: </label>10.1186/1745-6215-14-307  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amodiaquine--therapeutic use<br/>Antimalarials--adverse effects<br/>Artemether, Lumefantrine Drug Combination<br/>Artemisinins--adverse effects<br/>Child, Preschool<br/>Clindamycin--therapeutic use<br/>Clinical Protocols<br/>Democratic Republic of the Congo--epidemiology<br/>Drug Combinations<br/>Drug Resistance<br/>Drug Therapy, Combination<br/>Ethanolamines--therapeutic use<br/>Female<br/>Fluorenes--therapeutic use<br/>Humans<br/>Incidence<br/>Infant<br/>Longitudinal Studies<br/>Malaria, Falciparum--diagnosis<br/>Male<br/>Plasmodium falciparum--drug effects<br/>Quinine--therapeutic use<br/>Recurrence<br/>Research Design<br/>Retreatment<br/>Time Factors<br/>Treatment Outcome<br/>Uganda--epidemiology